Related Experiment Videos

[Suppurative-inflammatory diseases in newborn infants]

Vestnik Akademii Meditsinskikh Nauk SSSR
|January 1, 1990
PubMed

Insights

Neonatal suppurative-inflammatory diseases show changing causes and clinical signs. Preventive antibiotics in maternity hospitals are ineffective and harm infant microbial colonization.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Suppurative-inflammatory diseases in neonates pose significant health risks.
  • Understanding etiological patterns is crucial for effective treatment and prevention.
  • Antibiotic use in neonatal care requires careful consideration of its impact.

Purpose of the Study:

  • To analyze changes in the etiological patterns of neonatal suppurative-inflammatory diseases between 1978 and 1988.
  • To identify trends in microbial causes and associated clinical manifestations.
  • To evaluate the effectiveness and impact of preventive antibiotic therapy in neonates.

Main Methods:

  • Retrospective analysis of etiological data for neonatal suppurative-inflammatory diseases.
  • Tracking changes in microorganism prevalence over a decade (1978-1988).
  • Correlating etiological shifts with clinical presentations and antibiotic therapy practices.

Main Results:

  • Significant shifts observed in the etiological structure of neonatal infections.
  • Increasing prevalence of specific microorganism families and species identified.
  • Clinical manifestations evolved in response to changing etiologies.
  • Preventive antibiotic therapy in maternity settings demonstrated ineffectiveness.
  • Deleterious effects of preventive antibiotics on early postnatal microbial colonization were evident.

Conclusions:

  • Etiological patterns of neonatal suppurative-inflammatory diseases are dynamic and require ongoing surveillance.
  • Clinical management strategies must adapt to evolving microbial landscapes.
  • Routine preventive antibiotic administration in neonates is not recommended due to lack of efficacy and adverse effects on microbiome development.

Related Concept Videos